Federal contract award
HT940220F0010
THE TASK 2 VENDOR WILL SUPPORT TPHARM5 COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE HEALTH AGENCY |
| NAICS | 541611 — Administrative Management and General Management Consulting Services |
| PSC | R707 — Contract, Procurement, and Acquisition Support Services |
| Parent award / vehicle | GS00F045DA |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $3.2M |
| Current contract value | $3.2M |
| Potential contract value / ceiling | $3.2M |
| Start date | Apr 3, 2020 |
| Current end date | Oct 2, 2025 |
| Potential end date | Oct 2, 2025 |
| Latest award activity | Jul 10, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 15 of 15 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 10, 2025 | P00014 | $-114.4K | THE HEALTH PLAN INNOVATIVE SUPPORT (HPIS) PROGRAM SUPPORTS THE DEVELOPMENT AND IMPLEMENTATION OF UPCOMING TRICARE MANAGED CARE SUPPORT CONTRACTS (T-5). |
| May 28, 2025 | P00013 | $80.6K | THE HEALTH PLAN INNOVATIVE SUPPORT (HPIS) PROGRAM SUPPORTS THE DEVELOPMENT AND IMPLEMENTATION OF UPCOMING TRICARE MANAGED CARE SUPPORT CONTRACTS (T-5). |
| Feb 14, 2025 | P00012 | $161.1K | THE HEALTH PLAN INNOVATIVE SUPPORT (HPIS) PROGRAM SUPPORTS THE DEVELOPMENT AND IMPLEMENTATION OF UPCOMING TRICARE MANAGED CARE SUPPORT CONTRACTS (T-5). |
| Jan 29, 2025 | P00011 | $-23.2K | THE HEALTH PLAN INNOVATIVE SUPPORT (HPIS) PROGRAM SUPPORTS THE DEVELOPMENT AND IMPLEMENTATION OF UPCOMING TRICARE MANAGED CARE SUPPORT CONTRACTS (T-5). |
| Mar 19, 2024 | P00010 | $939.5K | COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. |
| Mar 15, 2024 | P00009 | $-89.1K | TPHARM5 COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. |
| Aug 11, 2023 | P00008 | $409.0K | TRICARE PHARMACY 5TH GENERATION COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. |
| Jun 29, 2023 | P00007 | $0 | THE TASK 2 VENDOR WILL SUPPORT TPHARM5 COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. |
| Mar 30, 2023 | P00006 | $494.0K | THE TASK 2 VENDOR WILL SUPPORT TPHARM5 COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. |
| Aug 10, 2022 | P00005 | $-61.8K | THE TASK 2 VENDOR WILL SUPPORT TPHARM5 COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. |
| Mar 23, 2022 | P00004 | $484.7K | THE TASK 2 VENDOR WILL SUPPORT TPHARM5 COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. |
| Sep 22, 2021 | P00003 | $-107.3K | THE TASK 2 VENDOR WILL SUPPORT TPHARM5 COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. |
| Mar 23, 2021 | P00002 | $483.6K | THE TASK 2 VENDOR WILL SUPPORT TPHARM5 COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. |
| May 1, 2020 | P00001 | $0 | THE TASK 2 VENDOR WILL SUPPORT TPHARM5 COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. |
| Apr 3, 2020 | 0 | $522.7K | THE TASK 2 VENDOR WILL SUPPORT TPHARM5 COST ESTIMATING AND PHARMACY BENEFIT OPTIMIZATION EFFORTS. |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.